期刊文献+

神经症状/神经缺陷评分与神经传导速度诊断糖尿病周围神经病变的相关性 被引量:12

Comparison of neuropathy symptom score/neuropathy disability score and nerve conduction velocities in the diagnosis of diabetic peripheral neuropathy
原文传递
导出
摘要 目的 研究神经症状/神经缺陷评分(NSS/NDS)与神经传导速度(NCV)在诊断糖尿病周围神经病变(DPN)中的相关性,并探讨NSS/NDS的临床使用价值.方法 以679例同时测定了NSS/NDS评分和NCV的2型糖尿病患者为研究对象,男性404例,女性275例,平均年龄(59±ll)岁.以NCV作为诊断DPN的金标准,分析NSS/NDS评分诊断DPN的敏感度、特异度、阳性预测值、阴性预测值、准确度、约登指数、Kappa值(一致性)及相关性等.采用Spearman相关和多因素logistic逐步回归进行相关性分析.结果 NSS/NDS评分诊断DPN的敏感度、特异度、阳性预测值、阴性预测值、准确度、约登指数、一致性及相关性分别为68.0%、77.2%、86.5%、53.5%、71.0%、45.2%、0.405、0.424.当NSS≥5分或NDS≥6分时,患者有较高的NCV异常率(77.8% ~ 100%).NSS、NDS评分与NCV均呈正相关(r=0.292、0.358,均P<0.01),患者神经症状或体征越严重,越容易引起NCV的减慢.Logistic回归分析显示NSS/NDS评分诊断DPN的危险因素是病程、年龄和UAlb/Cr[比值比(OR)=1.085、1.051、1.002,均P<0.01].与NCV诊断DPN的危险因素相关性较好.结论 NSS/NDS评分与NCV诊断DPN有相关性,尤其是神经症状、神经缺陷严重时相关性更好.NSS/NDS评分操作简单快速,方便有效,可在临床中作为DPN的筛查. Objective To evaluate the efficacy and clinical value of the neuropathy symptom score/ neuropathy disability score (NSS/NDS) compared with nerve conduction velocities (NCV) in the diagnosis of diabetic peripheral neuropathy (DPN).Methods Observational study of 679 patients diagnosed with type 2 diabetes mellitus (404 males and 275 females,the average age was (59 ± 11) years) was performed using the standard NSS/NDS and NCV criteria for the diagnosis of DPN.Taking NCV as the gold standard,we compared NCV against NSS/NDS using the following parameters:sensitivity,specificity,positive and negative predictive values,Youden index,Kappa value and correlation.Correlation analysis was done by using Spearman correlation and multivariate logistic regression.Results The sensitivity,specificity,positive and negative predictive values,Youden index,Kappa value and correlation of NSS/NDS compared with NCV was 68.0%,77.2%,86.5%,53.5%,71.0%,45.2%,0.405,0.424,respectively.The abnormal rate of NCV of patients was more remarkable when NSS score ≥5 or NDS score ≥6 (77.8%-100%).NSS and NDS demonstrated an obvious positive association with NCV(r =0.292,0.358,both P < 0.01).The NCV values for each nerve showed a negative correlation with the severity of symptoms and signs.Logistic regression analysis showed that the risk factors of DPN were disease duration,age and urinary albumin-to-creatinine ratio when NSS/NDS were considered as the diagnostic criteria (odds rations (OR) =1.085,1.051,1.002,all P < 0.01).A similar result was observed with NCV.Conclusions NSS/NDS demonstrates a positive association with NCV,especially when neurological symptoms and neurological signs became more serious.NSS/NDS analysis is a simple,rapid,cheap and powerful screening tool for the diagnosis of DPN.
出处 《中华糖尿病杂志》 CAS CSCD 2014年第4期224-228,共5页 CHINESE JOURNAL OF DIABETES MELLITUS
基金 国家临床重点专科建设项目
关键词 糖尿病 2型 糖尿病神经病变 神经症状 神经缺陷评分 神经传导速度 Diabetes mellitus, type 2 Diabetic neuropathies Neuropathy symptom score/neuropathy disability score Nerve conduction velocities
  • 相关文献

参考文献18

  • 1Sumpio BE. Foot ulcers[ J]. N Engl J Med,2000,343:787-793.
  • 2Smith AG, Singleton JR. Diabetic neuropathy [ J ]. Continuum ( Minneap Miun) , 2012,18:60-84.
  • 3The Diabetes Control and Complications Trial Research Group. The effect of diabetes therapy on the development and progression of neuropathy[J].Ann Intern Med, 1995, 122:561-568.
  • 4Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study[ J]. Neurology, 1993,43:817-824.
  • 5Lee S J, Chun MH, Kim BR, et al. Measurements of anteroposterior and intersidal asymmetry in patients with diabetic peripheral neuropathy [J]. Am J Phys Med Rehabil, 2013,92 : 118-126.
  • 6Erbas T, Ertas M, Yucel A, et al. Prevalence of peripheral neuropathy and painful peripheral neuropathy in Turkish diabetic patients [ J ]. J Clin Neurophysiol,2011,28 : 51-55.
  • 7Gibbons CH, Freeman R, Veves A. Diabetic neuropathy: a cross- sectional study of the relationships among tests of neurophysiology [J]. Diabetes Care,2010,33:2629-2634.
  • 8Asad A, Hameed MA, Khan UA, et al. Reliability of the neurological scores for assessment of sensorimotor neuropathy in type 2 diabetics[J]. J Pak Med Assoc, 2010,60(3) :166-170.
  • 9Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[ J]. Diabet Med,1998 ,15 :539-553.
  • 10Young MJ, Bouhon AJ, Macleod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population [ J ]. Diabetologia, 1993, 36 : 150-154.

二级参考文献14

  • 1Rith-Najarian S,Branchaud C,Beaulieu O,et al.Reducing lowerextremity amputations due to diabetes.Application of the staged diabetes management approach in a primary care setting.J Fam Pract,1998,47:127-132.
  • 2Lavery LA,Wunderlich RP,Tredwell JL.Disease management for the diabetic foot:effectiveness of a diabetic foot prevention program to reduce amputations and hospitalizations.Diabetes Res Clin Pract,2005,70:31-37.
  • 3Young M J,Boulton A J,Mac Leod AF,et al.A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.Diabetologia,1993,36:150-154.
  • 4Feldman EL,Stevens MJ,Thomas PK,et al.A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy.Diabetes Care,1994,17:1281-1289.
  • 5Dimitrakoudis D,Bril V.Comparison of sensory testing on different toe surfaces:implications for neuropathy screening.Neurology,2002,59:611-613.
  • 6Young M J,Breddy JL,Veves A,et al.The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds.A prospective study.Diabetes Care,1994,17:557-560.
  • 7Leonard DR,Farooqi MH,Myers S.Restoration of sensation,reduced pain,and improved balance in subjects with diabetic peripheral neuropathy.Diabetes Care,2004,27:168-172.
  • 8杨土保,筛检试验与诊断试验.黄悦勤,主编.临床流行病学.北京:人民卫生出版社,2003,98-118.
  • 9Perkins BA,Olaleye D,Zinman B,et al.Simple screening tests for peripheral neuropathy in the diabetes clinic.Diabetes Care,2001,24:250-256.
  • 10Olaleye D,Perkins BA,Bril V.Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.Diabetes Res Clin Pract,2001,54:115-128.

共引文献121

同被引文献126

  • 1Shafna Sachedina,Cory Toth.Association of comorbidities with increasing severity of peripheral neuropathy in diabetes mellitus[J].World Journal of Diabetes,2013,4(4):135-144. 被引量:7
  • 2Wen-Shan Lv,Rui-Xia Sun,Yan-Yan Gao,Jun-Ping Wen,Rong-Fang Pan,Li Li,Jing Wang,Yu-Xin Xian,Cai-Xia Cao,Ming Zheng.Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes[J].World Journal of Gastroenterology,2013,19(20):3134-3142. 被引量:31
  • 3苏晓娟,吴岚.马来酸桂哌齐特联合甲钴胺治疗糖尿病周围神经病变疗效的Meta分析[J].中国老年学杂志,2015,35(2):338-341. 被引量:10
  • 4余俊先,张银娣.糖尿病周围神经病变的发病机制及药物治疗[J].中国医刊,2007,42(9):66-69. 被引量:61
  • 5沈雅舟 吴松华 邵福源 等.糖尿病慢性并发症[M].上海:上海医科大学出版社,1999.207-234.
  • 6Tsuzura S, Ikeda Y, Suehiro T, et al. Con'elation of plasma oxidized low - density iipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes [ J ]. Metabolism, 2004,53 ( 2 ) :297 - 230.
  • 7Xu Q, Pan J, Yu J, et al. Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic pe- ripheral neuropathy[ J]. Diabetes Res Clin Pract,2013, 101 (2) : 99-105.
  • 8Deng H, Yin J, Zhang J, et al. Meta-analysis of methylcobalamin alone and in combination with prostaglandin E1 in the treatment of diabetic peripheral neuropathy [J]. Endocrine, 2014,46 ( 3 ) : 445 -454.
  • 9Merecz A, Markiewicz L, Sliwinska A, et al. Analysis of oxidative DNA damage and its repair in Polish patients with diabetes melli- tus type 2 : Role in pathogenesis of diabetic neuropathy [J]. Adv Med Sci ,2015,60(2) :220-230.
  • 10Walker MJ Jr, Morris LM, Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L- methylfolate, methylcobalamin, and pyridoxal 5 "-phosphate [ J ]. Rev Neurol Dis ,2010,7 (4) : 132-139.

引证文献12

二级引证文献122

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部